Legal & General Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.43M | Buy |
1,804,203
+392,589
| +28% | +$1.83M | ﹤0.01% | 1279 |
|
2025
Q1 | $7.75M | Buy |
1,411,614
+1,181,147
| +513% | +$6.48M | ﹤0.01% | 1282 |
|
2024
Q4 | $781K | Buy |
230,467
+19,624
| +9% | +$66.5K | ﹤0.01% | 2320 |
|
2024
Q3 | $601K | Buy |
210,843
+195,973
| +1,318% | +$559K | ﹤0.01% | 2399 |
|
2024
Q2 | $33.5K | Buy |
14,870
+323
| +2% | +$727 | ﹤0.01% | 2860 |
|
2024
Q1 | $32.1K | Hold |
14,547
| – | – | ﹤0.01% | 2842 |
|
2023
Q4 | $34.2K | Sell |
14,547
-788
| -5% | -$1.85K | ﹤0.01% | 2867 |
|
2023
Q3 | $28.5K | Sell |
15,335
-1,323
| -8% | -$2.46K | ﹤0.01% | 2933 |
|
2023
Q2 | $43.6K | Buy |
16,658
+84
| +0.5% | +$220 | ﹤0.01% | 2890 |
|
2023
Q1 | $26.9K | Hold |
16,574
| – | – | ﹤0.01% | 2988 |
|
2022
Q4 | $22K | Hold |
16,574
| – | – | ﹤0.01% | 3131 |
|
2022
Q3 | $26K | Sell |
16,574
-8,959
| -35% | -$14.1K | ﹤0.01% | 3141 |
|
2022
Q2 | $39K | Buy |
+25,533
| New | +$39K | ﹤0.01% | 3047 |
|
2021
Q2 | – | Sell |
-5,109
| Closed | -$23K | – | 3664 |
|
2021
Q1 | $23K | Sell |
5,109
-22,799
| -82% | -$103K | ﹤0.01% | 3080 |
|
2020
Q4 | $138K | Buy |
27,908
+22,500
| +416% | +$111K | ﹤0.01% | 2501 |
|
2020
Q3 | $32K | Sell |
5,408
-1,050
| -16% | -$6.21K | ﹤0.01% | 2829 |
|
2020
Q2 | $17K | Buy |
6,458
+324
| +5% | +$853 | ﹤0.01% | 3140 |
|
2020
Q1 | $13K | Buy |
6,134
+709
| +13% | +$1.5K | ﹤0.01% | 3097 |
|
2019
Q4 | $38K | Buy |
5,425
+964
| +22% | +$6.75K | ﹤0.01% | 2931 |
|
2019
Q3 | $44K | Hold |
4,461
| – | – | ﹤0.01% | 2791 |
|
2019
Q2 | $48K | Buy |
4,461
+974
| +28% | +$10.5K | ﹤0.01% | 2794 |
|
2019
Q1 | $35K | Buy |
3,487
+2,482
| +247% | +$24.9K | ﹤0.01% | 2858 |
|
2018
Q4 | $17K | Hold |
1,005
| – | – | ﹤0.01% | 3149 |
|
2018
Q3 | $18K | Buy |
+1,005
| New | +$18K | ﹤0.01% | 3238 |
|